L
ymphomas, the sixth-leading cause of human cancer death and fourth greatest in economic impact, are increasing in incidence (1) . Controlling lymphoma requires early diagnosis, accurate categorization, and understanding pathogenesis (2) . Lymphomas were first categorized by gross morphology, then microscopic morphology, and now gene expression. An example of molecular definition for lymphomas is overexpression of the Hodgkin's disease antigen, CD30, a tumor necrosis factor receptor (TNFR) II family member. A diverse range of Hodgkin's and many non-Hodgkin's lymphomas are CD30 hi , suggesting that common pathways are involved in lymphomagenesis. CD30 signaling in normal lymphocytes promotes not only survival and proliferation but also cell death. In contrast, CD30 expression in neoplastic cells promotes survival and proliferation (3, 4) . Mechanistic understanding of carcinogenesis and cancer regression requires animal models. However, no natural CD30 hi lymphoma animal models are known.
Marek's disease (MD) has contributed greatly to understanding herpesvirus oncogenicity and has many biological parallels with Epstein-Barr ␥-herpesvirus (EBV) (5) . Despite having different genome structures, EBV and MD ␣-herpesvirus (MDV) evolved the similar life strategies of lymphotrophy and lymphomagenesis. MDV-transformed T lymphocytes overexpress a host-encoded antigen recognized by the mAb AV37 (6) .
The AV37 antigen is Marek's-associated tumor surface antigen (MATSA) (7) . MATSAs were central to demonstrating that hostencoded antigens may be aberrantly expressed after herpesvirus transformation, yet no MATSA has ever been definitively identified. We show that AV37 recognizes chicken CD30 and lymphomagenic MDV of poultry is a naturally occurring model for CD30 hi lymphoma. EBV-induced lymphomas are also CD30 hi (8) . We propose that CD30 overexpression is an evolutionarily conserved response after, or to, lymphoid neoplastic-transformation regardless of etiology and that EBV and MDV evolved convergent strategies to survive in lymphocytes by disrupting homologous molecular pathways.
Materials and Methods
Chickens and MDV. Specified pathogen-free, MDV maternalantibody-negative inbred White Leghorn chickens [susceptible (line 7 2 ) or resistant (line 6 1 ) to MD] and commercial Ross ϫ Ross broiler chickens and oncogenic MDV strain HPRS-16 were used (9) .
Identification of Chicken CD30. The CD30 antigen was detected from an MDV-transformed cell line HP9 lysate by SDS͞PAGE (native and reduced), Western blotting (Hybond-C membrane; Amersham Pharmacia Biosciences), and immunostaining using AV37 followed by goat anti-mouse Ig-horseradish peroxidase (10) and enhanced chemiluminescence (Amersham Pharmacia Biosciences). CD30 cDNA was cloned and sequenced after magnetic enrichment of COS 7 cells transfected with a cDNA library derived from HP9 (in the eukaryote vector pCINx maintained in DH5␣ Escherichia coli), using AV37 as described (11) (GenBank accession nos. NM204444, AJ276964.1, and GI:28950398). CD30 was isolated from 10 10 HP9 cells by immunoaffinity chromatography (12) using protein A-purified AV37 coupled to CNBr-activated Sepharose (Amersham Pharmacia Biosciences), blotted to poly(vinylidene difluoride) membrane (Sequi-blot, Bio-Rad) from SDS͞PAGE, stained (naphthol blue-black, Sigma), excised, and N-terminalsequenced with a Procise 492 protein sequencer (Applied Biosystems).
The TNFR domains of chicken CD30 were aligned (CLUSTALW; ref. 13 ) with the core set of domains defined in the Pfam database and other known chicken TNFR domains. PROTDIST and FITCH (PHYLIP package; ref. 14) were used to generate a tree relating the domains. Rat sequences and branches most distal to the chicken CD30 domains were removed; the resultant set was analyzed in the same way, including bootstrap calculation (CONSENSE programs) with 100 data sets.
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Association of CD30 and MDV Meq Putative Oncogene Expression in
Vivo. The anti-Meq mAb (23b46) (17) and a mAb recognizing CD4 were used together with AV37 in double-staining flow cytometry experiments on permeabilized MD-lymphoma cells, isolated directly from line 7 2 lymphomas (four nerve, four ovary, two heart, and two liver) as described (6) CD30 Serum Ig After MDV Infection. Ten line 6 1 and 10 line 7 2 chickens were infected with HPRS-16 at 1, 7, and 14 days of age with HPRS-16. Sera were taken at 28 days of age and tested in triplicate for anti-chicken CD30 Ig by dissociation enhanced lanthanide fluorescence immunoassay (DELFIA) with a Victor 1420 plate reader (Wallac) as described (20) . Salmonella antigen plus antiSalmonella Ig ϩ chicken serum was the positive control. Optimal antigen concentration was determined by using purified chicken CD30 and serially diluted AV37. At 1͞10 dilution, 5 of 10 line 6 1 samples were positive, and these samples were then specificitytested by preabsorption. DELFIA plates were incubated (16 h; 4°C) with either chicken CD30 or horse serum then washed. Matched sera samples (1:10 dilution) were incubated (16 h; 4°C) in each plate. After incubation, sera were removed, and the plates were washed and then analyzed for anti-chicken CD30 Ig by DELFIA.
Results

CD30 Is Overexpressed on Neoplastically Transformed MD Lymphoma
Cells. The antigen recognized by AV37 has an apparent native and reduced molecular mass of Ϸ70 kDa ( Fig. 1) . BLAST searches (Table 2 ). TRAF 1, 2, and 3 binding motif is shown in bold. TRAF 1 and 2 motif is underlined. showed our cDNA sequence (encoding 467 aa) was most similar to human and mouse CD30 but contained four extracellular TNFR repeats, rather than the three in human and mouse (Figs. 2 and 3).
The chicken TNFR repeats 1-3 are most similar to their mammalian equivalents, but the fourth was not clearly related to any other CD30 TNFR repeat (Figs. 2 and 3A) . Overall, the chicken CD30 cytoplasmic region has low similarity to its mammalian counterparts; it has binding motifs for signal transducing TNFR-associated factor (TRAF) 1, 2, and 3 molecules, but not the TRAF6͞TNFR-associated protein (TTRAP) motif present in human and mouse CD30 (21) (Fig. 2 and Table 2 ). In the chicken either (i) TTRAP does not exist, (ii) CD30 does not bind TTRAP, or (iii) TTRAP has extremely low homology to human and mouse TTRAP. Notably, a unique 22-aa sequence in the cytoplasmic domain is highly conserved between chicken, human, and mouse ( Fig. 2 and Table 2 ). This exceptional conservation, within an otherwise divergent region, suggests this sequence is important. Principles defined in multispecies comparative genomic analyses support this assertion (22) . Possibly it is a novel signal transduction region. A potential phosphotyrosine, although not part of a typical Src homlogy 2 binding motif, is present. We found no existing reference to function, or potential function, for this or any similar sequence. BLAST searches reveal the sequence is unique to CD30.
The chicken CD30 promoter includes sequences defined in human and mouse CD30 as transcription factor binding sites (23) . Specifically, chicken CD30 has 15 predicted high-stringency AP-1 transcription factor binding sites (Supporting Text and Fig.  6 , which is published as supporting information on the PNAS web site), suggesting the possibility of a direct functional relationship between the MDV AP-1 transcription factor homologue Meq and CD30 expression in MD.
CD30 and MDV Meq Oncogene Expression Are Associated in Vivo.
MDV Meq is homologous to the host AP-1 trancription factor c-Jun, is unique to oncogenic MDV, and has oncogenic characteristics (24) . Meq mRNA expression positively correlates with intensity of AV37 immunostaining in MD lymphoma cells (17) . We suggest a functional link between Meq and CD30. However, Meq protein has never been associated with neoplastic transformation in vivo. We found Meq protein expression directly positively associates with CD30 expression, but not CD4 expression, on cells taken from MD lymphomas ex vivo (Fig. 4A) , i.e., the CD30 hi cells, which are the neoplastically transformed cells in MD lymphomas (6) , contain most Meq protein in vivo. As Meq is expressed in both latent and productive MDV life cycles (24) , the amount of Meq protein, rather than just its presence, appears important to its proposed oncogenicity in vivo. . MDV, ALV, and REV-T all neoplastically transform lymphocytes by different mechanisms, yet their lymphomas overexpress CD30. Each virus may subvert the CD30 signaling pathway, and͞or CD30 overexpression is a conserved response by chicken lymphocytes to some types of neoplastic transformation. The differences between the ALV-transformed cell lines are intriguing. These differences could simply be caused by loss of surface antigen expression after repeated culture; for example, one MDV-transformed cell line is unique among those we have tested in that it does not express CD30 (17) . The mechanisms involved in CD30 overexpression in ALV-transformed cells remain to be elucidated.
Soluble CD30 Is Present in Chicken Plasma.
In mammals, two forms of CD30 exist: a membrane-bound form and a soluble form found in blood. Soluble CD30 is a diagnostic maker for T helper 2-biased immune responses in infections and allergy (25) and lymphoproliferative disorders (26) . The peptides IRGTSETD-VSCEECPPGTFSDQSSSTDVCK and SCPMDPDEDCM-RCGPEQYLNQSPK (charge, X-correlation and delta correlation value, respectively: ϩ2, 2.72, and 0.25; ϩ2, 2.60, and 0.10) were present in the plasma of uninfected outbred chickens. These peptides are present in the extracellular region of chicken CD30. BLAST searches of the chicken genome sequence using these peptides show that they are unique to CD30.
CD30-Specific Immunity. Five tumor antigen families are defined: differentiation antigens, tumor-specific shared antigens, tumorspecific mutated host antigens, virus antigens, and overexpressed normal͞ubiquitous antigens (20) . Intuitively, antigens in the first four families contain foreign immunogenic epitopes. Less intuitively, overexpressed normal͞ubiquitous antigens are also immunogenic and, like autoantigens, overcome peripheral immune tolerance to activate low-affinity lymphocytes after antigen expression exceeds defined thresholds (27) (28) (29) . Most identified tumor antigens to which weak T cell responses occur are nonmutated self-antigens (20) .
We investigated whether anti-CD30-specific immunity exists after MDV infection. In the chicken, low-affinity cytotoxic lymphocyte (CTL) responses have never been measured. However, antigen-specific serum Ig directly correlates with antigen-specific CTL regardless of affinity (30) . We detected chicken CD30-specific specific serum Ig after MDV HPRS-16 superinfection of genetically MDresistant inbred chickens detected by dissociation enhanced lanthanide fluorescence immunoassay; chicken CD30-specific serum Ig titers could be diluted (i) and could be ablated by incubation with affinity-purified chicken CD30 but not horse serum (ii). Sal, Salmonella (positive control). serum Ig only after HPRS-16 infection of genetically MD-resistant inbred line 6 1 chickens but not after infection of MD-susceptible line 7 2 chickens. This Ig could be titered and was eliminated after incubation with affinity-purified chicken CD30 but not horse serum (Fig. 4B ).
Discussion
The chicken CD30 mRNA sequence and the chicken genome sequence data together allow inferences about the evolution of the CD30 molecule in vertebrates (Fig. 5 , Supporting Text, and Fig. 7 and Tables 3 and 4 , which are published as supporting information on the PNAS web site). The segment of human CD30 from the middle of repeat 1 to the middle of repeat 3 has exceptionally high similarity to the TNFR repeat regions further toward the C terminus (84% amino acid identity), suggesting that these two segments of human CD30 are the result of a duplication event. Duplication of a genomic region including exons 3 and 4 of a mouse-like ancestral gene, and its insertion within the intron between exons 6 and 7 would produce the exact structure of the modern human gene, including the preservation of all relevant splice sites and their phases. The same result could have been achieved by a direct tandem duplication of exons 3-6, followed by the deletion of the duplicated versions of exons 5 and 6. The effective result is the insertion of 2 1 ⁄2 TNFR repeats within the stem portion of the ancestral molecule. The absence of this duplication in the even older chicken gene confirms that mouse CD30 represents the ancestral mammalian gene structure.
We suggest human CD30 evolved from a common precursor by duplication of a segment whose ends are within introns 2 and 4 and insertion of the duplicated segment into another intron. This could have been the result of a simpler mechanism in which a tandem duplication including exons 3-6, followed by a two-exon deletion. Such a route to the evolution of human CD30 is consistent with the gene structures of the human and mouse genes, including the phases of the intron͞exon boundaries at all relevant locations (see Supporting Text). Our suggestion that the gene has evolved by this duplication, including one full and two half repeats, defines a relationship between the structures of human and mouse CD30 (reflected in Figs. 2 and 5) . The human molecule is longer, potentially having two ligand binding sites. These changes may have significant effects on biological function.
In a cancer biology context, our work demonstrates that MD of poultry is a naturally occurring model for CD30 Many human viruses perturb CD30 expression (31) (32) (33) (34) (35) (36) (37) (38) . Disruption of the CD30 pathway must be fundamental, or at least beneficial, to virus survival. Notably, CD30 signaling promotes T helper 2 cytokine secretion (3, 4) , and disruption of the normal CD30 signaling system in CD30-ligand deficient mice results in diminished primary CD8 ϩ T lymphocyte clonal expansion, clonal contraction after primary expansion, and aberrant anamnestic CD8 ϩ T lymphocyte expansion (39) . We hypothesize that herpesviruses convergently evolved mechanisms to increase CD30 expression and thus CD30 signaling to promote a T helper 2 environment, which would be inconsistent with cell-mediated immunity.
In addition, the longest-term persistence for any lymphotrophic virus would be achieved in memory lymphocytes. A logical explanation for herpesvirus-induced neoplastic transformation of lymphocytes is that it is an incidental consequence of increasing the lifespan of latently infected memory lymphocytes. Memory lymphocytes have increased proliferation and decreased death; deregulated cell proliferation and protection from cell death (40) are essential for survival of neoplastically transformed cells in vivo. It is a small conceptual step to either further increase proliferation and͞or decrease death of memory lymphocytes such that accumulation of these cells (i.e., lymphoma) results. CD30 up-regulation often coincides with memory lymphocyte marker expression (3, 4) . We propose that EBV and MDV convergently evolved mechanisms to disrupt pathways involved in memory lymphocyte maintenance and that CD30 may be involved.
The EBV gene LMP-1 is critical for EBV neoplastic transformation (41, 42) . LMP-1 disrupts CD30 signaling by associating with TRAF 1, 2, and 3 (43) at the cell membrane, which then activate NF-B (44, 45), promote T helper 2 cytokine production and cell proliferation, and up-regulate costimulatory molecules (including CD30). We propose that MDV Meq also disrupts the CD30 signaling pathway, but does so in the nucleus at the level of CD30 transcription. Avian and human oncogenic herpesviruses apparently have convergently evolved mechanisms to perturb the CD30 signaling pathway. Meq is an AP-1 transcription factor homologue. AP-1 transcription factors are essential for cell proliferation; they activate oncogene, growth factor, and cytokine transcription (28 (49) . The existence of tumor-infiltrating lymphocytes, specific to all classes of tumor antigens, is well established even in progressing tumors (20) . Immune-escape mechanisms must allow lymphomagenesis in MD-susceptible chickens despite high amounts of Meq. A T helper 2 environment, as postulated above, may be critical in such immune escape.
Last, evidence for natural tumor immunity in MD exists, but immunogenic tumor antigens per se have never been definitively identified (50) . We detected CD30-specific Ig after MDV infection of MD-resistant chickens. It could be that CD30 is only immunogenic in MD-resistant chickens, autoantigen immune tolerance in the susceptible chickens is greater than in resistant chickens, or B lymphocytolysis in susceptible chickens is so great that few specific B lymphocytes survive to produce CD30-specific Ig. Regardless, the presence of specific Ig to CD30 supports previous suggestions that antitumor immunity, especially that directed toward host-encoded antigens (50) , may exist in MD.
